Companies/CN/301281

科源制药 · SHANDONG KEYUAN PHARMACEUTICAL CO., LTD.

Income flow

Annual
301281 10-K Income StatementPeriod 2025-12-31Source 10-K
Net salesCNY 398M-14% Y/YRevenueCNY 398M-14% Y/Y

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · CNY
By activity
By activityCNY 398M
  • 化学药品制剂CNY 169M42.5%
  • 化学原料药CNY 164M41.3%
  • 中间体CNY 62M15.5%
  • 其他业务收入CNY 3M0.8%
By geography
By geographyCNY 398M
  • 华东CNY 194M48.8%
  • 华北CNY 83M20.8%
  • 境外CNY 44M11.0%
  • 西南CNY 34M8.6%
  • 华中CNY 18M4.5%
  • 东北CNY 12M3.0%
  • 华南CNY 10M2.5%
  • 西北CNY 3M0.8%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.12%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0.05PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.14.2%Shares outTotal shares currently outstanding (issued and not retired).108.3MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).57.0M
Dividend calendar
Ex-dividend
2026-06-16
Last cash
0.05 · 2026-06-16
Stock splits
  1. 1.4:12023-05-26

Valuation

Trailing PE 195.1 (2025-12-31)PE trend

Fiscal PE3

PeriodEPSClosePE
2025-12-310.1529.27195.1
2024-12-310.5629.753.0
2023-12-310.7633.3843.9

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.